key: cord-0833199-b6ewpdkc authors: Sainz, Talía; Udaondo, Clara; Méndez-Echevarría, Ana; Calvo, Cristina title: Lung Ultrasound for Evaluation of COVID-19 in Children date: 2020-11-07 journal: Arch Bronconeumol DOI: 10.1016/j.arbres.2020.10.013 sha: 07b7bd577dad233ad478fae5c9cfdebeff72919f doc_id: 833199 cord_uid: b6ewpdkc nan Although the evidence is still limited, studies describing the course of SARS-COV-2 infection suggest that the disease is mild in children. Most frequent complication is pneumonia, which occurs between 30-80% of cases, eventually requiring hospitalization [1] [2] [3] . Pulmonary involvement has been described in children and adults in pauci or even asymptomatic patients, especially when computerized tomography (CT) is used. In fact, the sensitivity of CT has been suggested to be even higher than PCR for COVID-19 diagnosis, but is not justified in children 4 . In recent years, point-of-care ultrasound (POCUS) is being increasingly used in pediatrics, as it is rapid, portable, repeatable, and non-ionizing. Specific patterns of lung ultrasound (LU) have shown to be useful in the differential diagnosis of pneumonia or acute bronchiolitis, with potential for prognosis 5, 6, 7 . First case series describing main ultrasound findings in children with confirmed COVID-19 pneumonia have been published recently, suggesting a pulmonary involvement similar to the one described in other viral infections 8 . The aim of this study was to address the usefulness of point-of-care LU, performed by paediatricians, to address pulmonary involvement in children with symptoms considered possibly attributable to SARS-CoV-2, during the first pandemic wave in Madrid. We performed a prospective observational cohort study, including patients that consulted with symptoms attributable to SARS-CoV-2 infection, from April to June 2020 at the Paediatrics Department of a tertiary hospital in Madrid. The study protocol was reviewed and accepted by the local Ethics Committee. Patients below 18 years of age evaluated for fever and/or respiratory symptoms were eligible for inclusion in the study. Exclusion criteria were: chronic lung disease, congenital heart disease, immunodeficiency, and congenital or anatomical defects of the airway. A total of 20 patients were included in this pilot study, with a median age of 5.2 years [IQR: 2.9-11.4], 65% were male. All patients were symptomatic, presenting with fever (80%), cough (55%), short of breathing (40%) and 45% were admitted for a median of 4.5 days [IQR: [4] [5] [6] [7] [8] [9] [10] . Median duration of symptoms was 5 days [IQR: 2.5-8.5] and 25% of all patients needed oxygen support. SARS-CoV-2 infection was confirmed in 50% of patients either by PCR (42%) or by a positive serology (8%). In two cases, an alternate aetiology was found (one mycoplasma, one metapneumovirus). No differences were found in epidemiological and clinical variables between COVID-19 confirmed and unconfirmed cases. Three cases (15%) were transferred to PICU without fatalities. All but one patient had abnormalities on the chest X-ray, mostly ground glass opacities (35%), perihilar infiltrates (30%) and consolidations (30%), with no differences between the groups (Table 1) The accuracy of PCR for the diagnosis of SARS-Co-V infection seems to be lower in children compared to adult patients 10 . Chest X-ray is unspecific in most cases, and point of care ultrasound has been suggested as a promising tool by some paediatric studies 8 . The accuracy of LU in detecting paediatric pneumonia of any etiology has been extensively proven 5, 9, 11 , and the scarce data in the literature suggest that the accuracy in the context of COVID-19 is comparable 8 . Main COVID-19 findings include pleural irregularities, vertical artifacts, areas of white lung and subpleural consolidations; all characteristic findings in the context of other viral respiratory infections such as acute bronchiolitis 6, 12 . Results of our study support these findings, with no abnormalities characterizing COVID-19. Although previous studies including infants admitted with acute bronchiolitis suggest that LU might help predicting clinical outcome, larger studies including severe cases of COVID-19 will be needed in order to test its role in patient stratification. In this context, the use of POCUS has aroused great interest among clinicians managing infected adults. In view of the recommendation of prono position to optimize ventilation of adults suffering from COVID-19, one could expect to find greater involvement when scanning the posterior wall, as described in acute bronchiolitis, where both B-lines and confluent B-lines are seen more often in the posterior area, but no differences were found in our series. SARS-CoV-2 infection in ambulatroy and hospitalized Spanish children Ten key points about COVID-19 in children: the shadows on the wall Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases Prospective evaluation of point-of-care ultrasonography for the diagnosis of pneumonia in children and young adults Lung ultrasound in bronchiolitis: Comparison with chest X-ray Point-of-care lung ultrasound in young children with respiratory tract infections and wheeze Lung Ultrasound in Children with COVID-19: Preliminary Findings Ultrasound diagnosis of pneumonia in children False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications Lung ultrasonography: A viable alternative to chest radiography in children with suspected pneumonia? Lung ultrasound for prediction of respiratory support in infants with acute bronchiolitis: a cohort study This is the first study that explores the usefulness of LU as a tool for identification of COVID-19 among children presenting with respiratory symptoms. Our study has several limitations, including the small sample size and the impossibility to completely exclude SARS-COV-2 infection and scans were not performed by a single person. Recruitment is ongoing to validate the usefulness of point of care ultrasound in children suffering from COVID-19.